Raloxifene [orch, phsu]
Fractures [inpo]
postmenopausal [tmco]
Women [popg]
Osteoporosis [dsyn]
Recently [tmco]
Selective Estrogen Receptor Modulators [horm, phsu]
Management [ocac]
Osteoporosis [dsyn]
Based [ftcn]
properties [qlco]
Estrogens [horm, phsu, strd]
Safety [hcpp]
Profile [lbpr]
Including [ftcn]
Benefits [qnco]
Breast [bpoc]
Heart [bpoc]
cognitive function [menp]
Raloxifene [orch, phsu]
Selective Estrogen Receptor Modulator [horm, phsu]
Market [geoa]
treatment [ftcn]
Osteoporosis [dsyn]
reduction [npop]
Spinal fracture [inpo]
Patients [podg]
Bone Mineral Density [clna]
Vertebral Fracture [inpo]
Raloxifene [orch, phsu]
Fractures [inpo]
High Risk [qlco]
Patients [podg]
Decrease [qlco]
Type I Procollagen [aapp, bacs]
Terminal [tmco]
Propeptide [aapp]
account [idcn]
reduction [npop]
Vertebral Fracture [inpo]
Raloxifene [orch, phsu]
Reduced [qlco]
Estrogen receptor positive [lbtr]
Invasive Breast Cancer [neop]
Subject [grup]
Increased [qnco]
CARDIOVASCULAR [bdsy]
baseline [bodm]
Assigned [ftcn]
Raloxifene [orch, phsu]
Decrease [qlco]
cardiovascular events [fndg]
Compared [acty]
placebo [topp]
Definite [qlco]
Fracture [inpo]
Efficacy [qlco]
Raloxifene [orch, phsu]
Spine [bpoc]
spine fracture [inpo]
High Risk [qlco]
Patients [podg]
Breast [bpoc]
Heart [bpoc]
Make [ftcn]
Compound [qlco]
Approach [spco]
Women [popg]
Presenting [idcn]
Osteoporosis [dsyn]
